Approach to the difficult pediatric asthmatic.
Wheezing in infants and children presents a difficult differential diagnosis contingent on the presenting symptoms and age of the child. A determination of the anatomy of the lower airway, combined with allergic, infectious, and noninfectious irritants, is requisite to a complete evaluation. The intervention strategies to decrease wheezing and bronchial hyperresponsiveness may include both nonpharmacologic and pharmacologic management. The nonpharmacologic management of asthma in children is contingent on aggressive treatment of dietary protein sensitivity and strict environmental control. The treatment of bronchial hyperresponsiveness with pharmacologic intervention in infants and children is relegated to the optimal use of sodium cromoglycate and inhaled corticosteroid.
Chipps
B E
BE
Capital Allergy and Respiratory Disease Center, Sacramento, CA 95819, USA.
Chipps
D R
DR
D000328:Adult; D018927:Anti-Asthmatic Agents / Q000008:administration & dosage / Q000627:therapeutic use; D001249:Asthma / Q000453:epidemiology / Q000209:etiology / Q000628:therapy; D016535:Bronchial Hyperreactivity / Q000628:therapy; D001999:Bronchoscopy; D002648:Child; D003550:Cystic Fibrosis / Q000150:complications; D005260:Female; D005512:Food Hypersensitivity; D005764:Gastroesophageal Reflux / Q000209:etiology; D006801:Humans; D007223:Infant; D008297:Male; D012135:Respiratory Sounds / Q000209:etiology; D012307:Risk Factors
D018927:Anti-Asthmatic Agents